1 | channel | 3,797 |
2 | carbonate | 769 |
3 | hydroxide | 437 |
4 | ionophore | 75 |
5 | dobesilate | 42 |
6 | channel-blocking | 14 |
7 | hydroxylapatite | 12 |
8 | fructoborate | 11 |
9 | aluminosilicate | 8 |
10 | chloride-induced | 7 |
11 | polycarbophil | 7 |
12 | -k+ | 6 |
13 | =1/2 | 6 |
14 | channel-specific | 6 |
15 | ion-channel | 6 |
16 | t-channel | 6 |
17 | channel-blocker | 5 |
18 | cytochemia | 5 |
19 | channel-blockers | 4 |
20 | hydroxide-based | 4 |
21 | resonium | 4 |
22 | carbonate-treated | 3 |
23 | channel-dependent | 3 |
24 | foldamer | 3 |
25 | microfluorimetry | 3 |
26 | pre-rinse | 3 |
27 | signaling-mediated | 3 |
28 | -current | 2 |
29 | 375-3000 | 2 |
30 | 3´- | 2 |
31 | alkali-metal | 2 |
32 | atpase-2a | 2 |
33 | carbide-coating | 2 |
34 | carbonate-based | 2 |
35 | carbonate/1000 | 2 |
36 | carbonate/triclosan | 2 |
37 | center-binding | 2 |
38 | channel-based | 2 |
39 | chloride-based | 2 |
40 | monilis | 2 |
41 | na+-channel | 2 |
42 | pei-coated | 2 |
43 | polyuronate | 2 |
44 | ranelate/vitamin | 2 |
45 | slow-channel | 2 |
46 | vernetzte | 2 |
47 | -1h-imidazol-2-yl | 1 |
48 | -5-oxo-3-pyrrolidinecarboxylate | 1 |
49 | -homo-freidinger | 1 |
50 | -ionophore | 1 |
51 | /angiotensin-receptor | 1 |
52 | /calcium-channel | 1 |
53 | /ioff | 1 |
54 | /ir | 1 |
55 | 3-labeled | 1 |
56 | 4-chlorophenylsulfanylacetate | 1 |
57 | acetylhomotaurinate | 1 |
58 | and-phosphate | 1 |
59 | antagonists-were | 1 |
60 | antagonistst | 1 |
61 | antagonization | 1 |
62 | binders/vitamin | 1 |
63 | bleached-kraft | 1 |
64 | buffer-n-hexane | 1 |
65 | carbimide | 1 |
66 | carbonate/1 | 1 |
67 | carbonate/1450 | 1 |
68 | carbonothioyl | 1 |
69 | chanel | 1 |
70 | channel-3.1 | 1 |
71 | channel-composing | 1 |
72 | channel-kqt-like | 1 |
73 | channel-openers | 1 |
74 | channel-selective | 1 |
75 | channel/gaba | 1 |
76 | channel/γ-aminobutyric | 1 |
77 | chlorocalumite | 1 |
78 | currentharmful | 1 |
79 | cyclobut-1-enylamino | 1 |
80 | dimagnesium | 1 |
81 | eth-yl | 1 |
82 | excretion/24 | 1 |
83 | finger-containing | 1 |
84 | first-d1-n5 | 1 |
85 | flux-mediated | 1 |
86 | he+au | 1 |
87 | heterocosy | 1 |
88 | hydrosulfide-induced | 1 |
89 | hypochloriteinduced | 1 |
90 | inhibitor/beta | 1 |
91 | intake-no-exercise | 1 |
92 | ionophore-stimulated | 1 |
93 | k+-channel | 1 |
94 | l-5-methyltetrahydrofolic | 1 |
95 | lactoseries | 1 |
96 | levulinate | 1 |
97 | metallo-β- | 1 |
98 | mica-fluorapatite | 1 |
99 | n-6-phenylhexanoyl-glycyl-l-tryptophan | 1 |
100 | n-protecting | 1 |
101 | nanobiotechnological | 1 |
102 | nitrate/polycarboxylate | 1 |
103 | n⋅5 | 1 |
104 | o-substituents | 1 |
105 | oxocarbonate | 1 |
106 | phosphate-coated | 1 |
107 | phosphate-nanocomplexes | 1 |
108 | phosphate/citrate | 1 |
109 | phosphates-hydroxyapatite | 1 |
110 | phosphocarbonate | 1 |
111 | potassium-adenosine | 1 |
112 | propionate-supplemented | 1 |
113 | pyrophosphate/triphosphoric | 1 |
114 | regimen/hpufsh-gonadotropin | 1 |
115 | release-activated | 1 |
116 | scheelite-type | 1 |
117 | score≥400 | 1 |
118 | second-largest | 1 |
119 | semichemical | 1 |
120 | sensitisor | 1 |
121 | sulfoaluminate | 1 |
122 | supplement-dependent | 1 |
123 | tert-butoxide-mediated | 1 |
124 | transport-deficient | 1 |
125 | transporting-polypeptide | 1 |
126 | triacrylate-co-n-isopropylacrylamide-co-ethylenedimethacrylate | 1 |
127 | zirconosiloxane | 1 |
128 | α1-subunits | 1 |
129 | σδ | 1 |
130 | ∼6.1 | 1 |
131 | ≤2.74 | 1 |
1 | -1h-imidazol-2-yl | 1 |
2 | -5-oxo-3-pyrrolidinecarboxylate | 1 |
3 | -current | 2 |
4 | -homo-freidinger | 1 |
5 | -ionophore | 1 |
6 | -k+ | 6 |
7 | /angiotensin-receptor | 1 |
8 | /calcium-channel | 1 |
9 | /ioff | 1 |
10 | /ir | 1 |
11 | 3-labeled | 1 |
12 | 375-3000 | 2 |
13 | 3´- | 2 |
14 | 4-chlorophenylsulfanylacetate | 1 |
15 | =1/2 | 6 |
16 | acetylhomotaurinate | 1 |
17 | alkali-metal | 2 |
18 | aluminosilicate | 8 |
19 | and-phosphate | 1 |
20 | antagonists-were | 1 |
21 | antagonistst | 1 |
22 | antagonization | 1 |
23 | atpase-2a | 2 |
24 | binders/vitamin | 1 |
25 | bleached-kraft | 1 |
26 | buffer-n-hexane | 1 |
27 | carbide-coating | 2 |
28 | carbimide | 1 |
29 | carbonate | 769 |
30 | carbonate-based | 2 |
31 | carbonate-treated | 3 |
32 | carbonate/1 | 1 |
33 | carbonate/1000 | 2 |
34 | carbonate/1450 | 1 |
35 | carbonate/triclosan | 2 |
36 | carbonothioyl | 1 |
37 | center-binding | 2 |
38 | chanel | 1 |
39 | channel | 3,797 |
40 | channel-3.1 | 1 |
41 | channel-based | 2 |
42 | channel-blocker | 5 |
43 | channel-blockers | 4 |
44 | channel-blocking | 14 |
45 | channel-composing | 1 |
46 | channel-dependent | 3 |
47 | channel-kqt-like | 1 |
48 | channel-openers | 1 |
49 | channel-selective | 1 |
50 | channel-specific | 6 |
51 | channel/gaba | 1 |
52 | channel/γ-aminobutyric | 1 |
53 | chloride-based | 2 |
54 | chloride-induced | 7 |
55 | chlorocalumite | 1 |
56 | currentharmful | 1 |
57 | cyclobut-1-enylamino | 1 |
58 | cytochemia | 5 |
59 | dimagnesium | 1 |
60 | dobesilate | 42 |
61 | eth-yl | 1 |
62 | excretion/24 | 1 |
63 | finger-containing | 1 |
64 | first-d1-n5 | 1 |
65 | flux-mediated | 1 |
66 | foldamer | 3 |
67 | fructoborate | 11 |
68 | he+au | 1 |
69 | heterocosy | 1 |
70 | hydrosulfide-induced | 1 |
71 | hydroxide | 437 |
72 | hydroxide-based | 4 |
73 | hydroxylapatite | 12 |
74 | hypochloriteinduced | 1 |
75 | inhibitor/beta | 1 |
76 | intake-no-exercise | 1 |
77 | ion-channel | 6 |
78 | ionophore | 75 |
79 | ionophore-stimulated | 1 |
80 | k+-channel | 1 |
81 | l-5-methyltetrahydrofolic | 1 |
82 | lactoseries | 1 |
83 | levulinate | 1 |
84 | metallo-β- | 1 |
85 | mica-fluorapatite | 1 |
86 | microfluorimetry | 3 |
87 | monilis | 2 |
88 | n-6-phenylhexanoyl-glycyl-l-tryptophan | 1 |
89 | n-protecting | 1 |
90 | na+-channel | 2 |
91 | nanobiotechnological | 1 |
92 | nitrate/polycarboxylate | 1 |
93 | n⋅5 | 1 |
94 | o-substituents | 1 |
95 | oxocarbonate | 1 |
96 | pei-coated | 2 |
97 | phosphate-coated | 1 |
98 | phosphate-nanocomplexes | 1 |
99 | phosphate/citrate | 1 |
100 | phosphates-hydroxyapatite | 1 |
101 | phosphocarbonate | 1 |
102 | polycarbophil | 7 |
103 | polyuronate | 2 |
104 | potassium-adenosine | 1 |
105 | pre-rinse | 3 |
106 | propionate-supplemented | 1 |
107 | pyrophosphate/triphosphoric | 1 |
108 | ranelate/vitamin | 2 |
109 | regimen/hpufsh-gonadotropin | 1 |
110 | release-activated | 1 |
111 | resonium | 4 |
112 | scheelite-type | 1 |
113 | score≥400 | 1 |
114 | second-largest | 1 |
115 | semichemical | 1 |
116 | sensitisor | 1 |
117 | signaling-mediated | 3 |
118 | slow-channel | 2 |
119 | sulfoaluminate | 1 |
120 | supplement-dependent | 1 |
121 | t-channel | 6 |
122 | tert-butoxide-mediated | 1 |
123 | transport-deficient | 1 |
124 | transporting-polypeptide | 1 |
125 | triacrylate-co-n-isopropylacrylamide-co-ethylenedimethacrylate | 1 |
126 | vernetzte | 2 |
127 | zirconosiloxane | 1 |
128 | α1-subunits | 1 |
129 | σδ | 1 |
130 | ∼6.1 | 1 |
131 | ≤2.74 | 1 |
1 | -k+ | 6 |
2 | metallo-β- | 1 |
3 | 3´- | 2 |
4 | carbonate/1000 | 2 |
5 | 375-3000 | 2 |
6 | score≥400 | 1 |
7 | carbonate/1450 | 1 |
8 | channel-3.1 | 1 |
9 | ∼6.1 | 1 |
10 | carbonate/1 | 1 |
11 | =1/2 | 6 |
12 | excretion/24 | 1 |
13 | ≤2.74 | 1 |
14 | first-d1-n5 | 1 |
15 | n⋅5 | 1 |
16 | atpase-2a | 2 |
17 | channel/gaba | 1 |
18 | cytochemia | 5 |
19 | inhibitor/beta | 1 |
20 | channel-specific | 6 |
21 | l-5-methyltetrahydrofolic | 1 |
22 | pyrophosphate/triphosphoric | 1 |
23 | channel/γ-aminobutyric | 1 |
24 | hydrosulfide-induced | 1 |
25 | chloride-induced | 7 |
26 | hypochloriteinduced | 1 |
27 | 3-labeled | 1 |
28 | chloride-based | 2 |
29 | hydroxide-based | 4 |
30 | carbonate-based | 2 |
31 | channel-based | 2 |
32 | carbonate-treated | 3 |
33 | tert-butoxide-mediated | 1 |
34 | signaling-mediated | 3 |
35 | flux-mediated | 1 |
36 | ionophore-stimulated | 1 |
37 | phosphate-coated | 1 |
38 | pei-coated | 2 |
39 | release-activated | 1 |
40 | propionate-supplemented | 1 |
41 | carbimide | 1 |
42 | transporting-polypeptide | 1 |
43 | hydroxide | 437 |
44 | channel-kqt-like | 1 |
45 | buffer-n-hexane | 1 |
46 | zirconosiloxane | 1 |
47 | potassium-adenosine | 1 |
48 | scheelite-type | 1 |
49 | antagonists-were | 1 |
50 | ionophore | 75 |
51 | -ionophore | 1 |
52 | intake-no-exercise | 1 |
53 | pre-rinse | 3 |
54 | aluminosilicate | 8 |
55 | and-phosphate | 1 |
56 | dobesilate | 42 |
57 | triacrylate-co-n-isopropylacrylamide-co-ethylenedimethacrylate | 1 |
58 | -5-oxo-3-pyrrolidinecarboxylate | 1 |
59 | nitrate/polycarboxylate | 1 |
60 | levulinate | 1 |
61 | sulfoaluminate | 1 |
62 | acetylhomotaurinate | 1 |
63 | carbonate | 769 |
64 | phosphocarbonate | 1 |
65 | oxocarbonate | 1 |
66 | polyuronate | 2 |
67 | fructoborate | 11 |
68 | phosphate/citrate | 1 |
69 | 4-chlorophenylsulfanylacetate | 1 |
70 | chlorocalumite | 1 |
71 | hydroxylapatite | 12 |
72 | mica-fluorapatite | 1 |
73 | phosphates-hydroxyapatite | 1 |
74 | vernetzte | 2 |
75 | channel-selective | 1 |
76 | /ioff | 1 |
77 | center-binding | 2 |
78 | channel-blocking | 14 |
79 | finger-containing | 1 |
80 | channel-composing | 1 |
81 | carbide-coating | 2 |
82 | n-protecting | 1 |
83 | nanobiotechnological | 1 |
84 | semichemical | 1 |
85 | alkali-metal | 2 |
86 | chanel | 1 |
87 | channel | 3,797 |
88 | na+-channel | 2 |
89 | k+-channel | 1 |
90 | /calcium-channel | 1 |
91 | ion-channel | 6 |
92 | t-channel | 6 |
93 | slow-channel | 2 |
94 | polycarbophil | 7 |
95 | currentharmful | 1 |
96 | -1h-imidazol-2-yl | 1 |
97 | eth-yl | 1 |
98 | carbonothioyl | 1 |
99 | resonium | 4 |
100 | dimagnesium | 1 |
101 | n-6-phenylhexanoyl-glycyl-l-tryptophan | 1 |
102 | carbonate/triclosan | 2 |
103 | ranelate/vitamin | 2 |
104 | binders/vitamin | 1 |
105 | regimen/hpufsh-gonadotropin | 1 |
106 | antagonization | 1 |
107 | cyclobut-1-enylamino | 1 |
108 | -homo-freidinger | 1 |
109 | channel-blocker | 5 |
110 | foldamer | 3 |
111 | /ir | 1 |
112 | sensitisor | 1 |
113 | /angiotensin-receptor | 1 |
114 | lactoseries | 1 |
115 | phosphate-nanocomplexes | 1 |
116 | monilis | 2 |
117 | channel-blockers | 4 |
118 | channel-openers | 1 |
119 | α1-subunits | 1 |
120 | o-substituents | 1 |
121 | bleached-kraft | 1 |
122 | channel-dependent | 3 |
123 | supplement-dependent | 1 |
124 | transport-deficient | 1 |
125 | -current | 2 |
126 | second-largest | 1 |
127 | antagonistst | 1 |
128 | he+au | 1 |
129 | microfluorimetry | 3 |
130 | heterocosy | 1 |
131 | σδ | 1 |